Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Elbasvir and Grazoprevir

Generic Name: Elbasvir and Grazoprevir

Overview

No overview information available.

Background

No background information available.

Indication

适用于治疗基因1、4型慢性丙肝的成年患者。

Associated Conditions

No associated conditions information available.

Clinical Trials

Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)

Phase 1

Completed

Posted: 2017/05/10

Sponsor:University of Pennsy...

ID:NCT03146741

Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)

Phase 4

Withdrawn

Posted: 2017/05/08

Sponsor:Merck Sharp & Dohme ...

ID:NCT03143998

Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant

Phase 4

Withdrawn

Posted: 2017/03/28

Sponsor:Massachusetts Genera...

ID:NCT03093740

The Dublin Zepatier Study

Phase 4

Terminated

Posted: 2016/09/12

Sponsor:Mater Misericordiae ...

ID:NCT02895958

Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients

Phase 4

Completed

Posted: 2016/05/24

Sponsor:Johns Hopkins Univer...

ID:NCT02781649

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy